Intravascular ultrasound (IVUS) developer Endosonics of Pleasanton,CA, has extended its product distribution relationship with Cordis.The deal gives Cordis, of Miami Lake, FL, exclusive distributionrights in North America and Europe to Endosonics IVUS
Intravascular ultrasound (IVUS) developer Endosonics of Pleasanton,CA, has extended its product distribution relationship with Cordis.The deal gives Cordis, of Miami Lake, FL, exclusive distributionrights in North America and Europe to Endosonics IVUS productsfor coronary applications. Cordis has agreed to provide fundingfor joint product development programs and made a $5 million equityinvestment in Endosonics.
Endosonics in January reported year-end financial results thatshowed revenues more than doubling, to $17.1 million from $8 millionin 1994. Its loss for the year narrowed, to $10.5 million comparedwith $13.3 million in 1994.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.